ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
M

ASCO 2022 on the Analysis of Peripheral Neuropathy in 1L DLBCL Using ClinROs and PROs in the POLARIX Study

By ASCO 2022 Conference Coverage FEATURING Marek Trneny
By ASCO 2022 Conference Coverage FEATURING Marek Trneny
30 views
June 23, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das
Lymphoma
04:26

2022 ASCO Annual Meeting "The Effects of AVM0703 Mobilization of End…

ASCO 2022 Conference Coverage

J. Dalpez

123 views
01:07

Lecture Summary - ASCO 2022 on the Phase 2 KEYNOTE-C11 Study: Sequen…

ASCO 2022 Conference Coverage

J. Winter

46 views
09:39

ASCO 2022 on the Phase 2 KEYNOTE-C11 Study: Sequential Pembro & Chem…

ASCO 2022 Conference Coverage

J. Winter

14 views
01:13

Lecture Summary - ASCO 2022 on the Phase III frontMIND Study: Tafasi…

ASCO 2022 Conference Coverage

U. Vitolo

43 views
08:45

ASCO 2022 on the Phase III frontMIND Study: Tafasitamab + Lenalidomi…

ASCO 2022 Conference Coverage

U. Vitolo

29 views
08:55

ASCO 2022 on the Analysis of Peripheral Neuropathy in 1L DLBCL Using…

ASCO 2022 Conference Coverage

M. Trneny

30 views
10:16

ASCO 2022 ADCs and CARs: Racing to Cure Aggresive Lymphoma

ASCO 2022 Conference Coverage

K. Patel

87 views
13:02

ASCO 2022 on the Predictive Value of TGFβ1/TGFBR2 Ratio for Evaluati…

ASCO 2022 Conference Coverage

V. Bandovkina

109 views
11:30

ASCO 2022 Expert Discussion: Current Treatment Approaches in Hemophi…

ASCO 2022 Conference Coverage

J. Bussel, C. Mcguinn

58 views
01:44

Lecture Summary - ASCO 2022 Treatment Patterns and Real-World Effect…

ASCO 2022 Conference Coverage

M. Di

9 views
05:39

ASCO 2022 Treatment Patterns and Real-World Effectiveness of Rituxim…

ASCO 2022 Conference Coverage

M. Di

100 views
05:16

ASCO 2022 Three-Year Follow-Up of Outcomes With KTE-X19 in R/R Mantl…

ASCO 2022 Conference Coverage

M. Wang

96 views
53

Lecture Summary - ASCO 2022 Three-Year Follow-Up of Outcomes With KT…

ASCO 2022 Conference Coverage

M. Wang

36 views
05:40

ASCO 2022 Brexucabtagene Autoleucel for R/R Mantle Cell Lymphoma: Re…

ASCO 2022 Conference Coverage

P. Jain

90 views
57

Lecture Summary - ASCO 2022 Brexucabtagene Autoleucel for R/R Mantle…

ASCO 2022 Conference Coverage

P. Jain

13 views
07:46

ASCO 2022 on the Initial Safety Run-in Results of the Phase III POLA…

ASCO 2022 Conference Coverage

M. Matasar

79 views
03:32

ASCO 2022 Correlates of Common Concerns in Older Cancer Survivors of…

ASCO 2022 Conference Coverage

M. Loh

20 views
52

Lecture Summary - ASCO 2022 Real World Experience of Combined Treatm…

ASCO 2022 Conference Coverage

M. Kalac

20 views
12:56

ASCO 2022 Real World Experience of Combined Treatment With Romidepsi…

ASCO 2022 Conference Coverage

M. Kalac

17 views
01:33

Lecture Summary - ASCO 2022 Bendamustine Rituximab vs. Ibrutinib as …

ASCO 2022 Conference Coverage

J. Abeykoon

106 views
10:06

ASCO 2022 Bendamustine Rituximab vs. Ibrutinib as Primary Therapy fo…

ASCO 2022 Conference Coverage

J. Abeykoon

1.7K views
42

Lecture Summary - ASCO 2022 on Clinical & PROs in a Phase III, Rando…

ASCO 2022 Conference Coverage

J. Westin

25 views
05:27

ASCO 2022 on Clinical & PROs in a Phase III, Randomized, Open-Label …

ASCO 2022 Conference Coverage

J. Westin

63 views
04:35

ASCO 2022 on CRC-403: A Phase 1/2 Study of bbT369, A Dual Targeting …

ASCO 2022 Conference Coverage

F. Locke

53 views
34

Lecture Summary - ASCO 2022 Updated Interim Analysis of the Randomiz…

ASCO 2022 Conference Coverage

C. Lee Batlevi

20 views
05:16

ASCO 2022 Updated Interim Analysis of the Randomized Phase 1b/3 Stud…

ASCO 2022 Conference Coverage

C. Lee Batlevi

69 views
05:13

ASCO 2022 PACIFIC Trial Updates: Response Kinetics, Safety & Efficac…

ASCO 2022 Conference Coverage

R. Steiner

415 views